News - Biotechnology

Expand National Biotechnology Devt Agency to All States - Okolo

18 January 2013

The Federal Government has been urged to expand the presence of the National Biotechnology Development Agency (NABDA) beyond Abuja to all the 36 states so that farmers can know about what the agency is doing. Dr. Simon Chukwuemeka Okolo, the ...

Click on the link to read the full article at AllAfrica.com (This link will open in a new window)

NIGERIA: Expand National Biotechnology Devt Agency to all states ? Okolo

18 January 2013

Dr Simon OkoloThe Federal Government has been urged to expand the presence of the National Biotechnology Development Agency (NABDA) beyond Abuja to all the 36 states so that farmers can know about what the agency is doing. Dr. Simon ...

Click on the link to read the full article at Codewit Global Network (This link will open in a new window)

Cytos Biotechnology updates phase II b trial of CYT003 in allergic asthma

17 January 2013

Cytos Biotechnology Ltd, a public biopharmaceutical company focused on the development of targeted immunotherapies, has provided an update on the phase II b clinical trial with its lead product candidate, CYT003, in allergic asthma. The clinical trial ...

Click on the link to read the full article at pharmabiz.com (This link will open in a new window)

4 Biotechnology Stocks to Buy Now

16 January 2013

This week, four Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an ?A? (?strong buy?) or ?B? overall (?buy?). This week, Aegerion Pharmaceuticals (NASDAQ:AEGR) is showing good progress as the company's ...

Click on the link to read the full article at Investorplace.com (This link will open in a new window)

Research and Markets: Chinese Markets for Biotechnology - 2012 Report ...

16 January 2013

China's demand for biotechnology has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, ...

Click on the link to read the full article at PharmiWeb.com (press release) (This link will open in a new window)

International Biotechnology strengthens its board

16 January 2013

International Biotechnology strengthens its board. 16 January 2013 | 07:43am. StockMarketWire.com - International Biotechnology Trust has appointed Jim Horsburgh as a non-executive director, with effect from 1 February. Horsburgh will also be appointed ...

Click on the link to read the full article at Stock Market Wire (This link will open in a new window)

Biocartis Strengthens Management Team with General Counsel Life Sciences ...

15 January 2013

LAUSANNE, Switzerland and MECHELEN, Belgium, January 15, 2013 /PRNewswire via COMTEX/ -- Biocartis, a molecular diagnostics company developing and commercializing innovative, high quality, easy to use platforms and clinically relevant oncology ...

Click on the link to read the full article at MarketWatch (press release) (This link will open in a new window)

RBCC Explores ?Target-Rich Environment' as Biotechnology Takes Over San ...

14 January 2013

The bay area became the biotechnology industry's focus beginning last Monday with Biotech Showcase 2013. OneMedForum SF 2013 and the J.P. Morgan 31st Annual Healthcare Conference all descended on San Francisco at once. RBCC CEO Patrick ...

Click on the link to read the full article at PharmaLive (press release) (subscription) (This link will open in a new window)

RBCC Explores 'Target-Rich Environment' As Biotechnology Takes Over San ...

14 January 2013

The bay area became the biotechnology industry's focus beginning last Monday with Biotech Showcase 2013. OneMedForum SF 2013 and the J.P. Morgan 31st Annual Healthcare Conference all descended on San Francisco at once. RBCC CEO Patrick ...

Click on the link to read the full article at TheStreet.com (press release) (This link will open in a new window)

Generex Biotechnology Corp. (OTC:GNBT) Regains on Expected Business ...

14 January 2013

This is the case of Generex Biotechnology Corp. (OTC:GNBT, GNBT message board), which jumped on the announcement that it will reach out to investors in a conference call to talk about the company's future and almost completed products. On January ...

Click on the link to read the full article at HotStocked (This link will open in a new window)

Showing 61-70 of 2557 news

Go to beginningPreviousNextGo to end